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Low-intensity ultrasound therapy (LIUST) has been described as a plausible treatment for chronic 
rhinosinusitis (CRS). 
Aims: To evaluate the short-term effects of continuous 1MHz LIUST on nasal obstruction in subjects 
with CRS. 
Material and Method: A cohort placebo-controlled study comprising 26 CRS adults (10 men, 16 
women), sequentially allocated into two groups: control-placebo (CP, n= 12) and treated with LIUST 
(US, n= 14). The treatment consisted of: ISATA = continuous 1MHz, 1W.cm-2 for four minutes in the 
maxillary sinuses and nasal septum. The equipment was switched off in the CP group. The degree 
of obstruction was assessed by the total volume of secretion expelled (VSEx) after nasal instillation 
of 5 mL saline solution (NaCl-0.9%) followed by nasal lavage. The volume of expired air (VEA) was 
assessed with a Glatzel mirror. 
Results: The data showed an increase (p<0.01) in VSEx and VEA after ultrasound therapy, suggesting 
a 64% improvement of nasal obstruction compared with the CP group. 
Conclusions: Continuous LIUST reduced nasal obstruction and congestionç it may be used effectively 
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INTRODUCTION
Rhinosinusitis may be described as inflammation of 
the nasosinusal mucosa due to infection, trauma, exposure 
to chemicals or allergens.1,2 Sinusitis without rhinitis is rare, 
but rhinitis may occur alone. Non-specific chronic infec-
tious rhinitis is often associated with sinusitis, and should 
be classified and treated as rhinosinusitis.3,4 Voegels et al.5 
reported that the prevalence of nasosinusal infection is 
high, and that it requires complex and prolonged therapy, 
particularly in the first and second decades of life.
The pathophysiology of rhinosinusitis consists of 
obstruction of paranasal sinus ostia (which aerate and drain 
the sinuses).5,6 Occlusion leads to intrasinus hypoxia and 
hypercapnia, vasodilation, increased capillary permeability, 
interstitial edema, hypertrophied mucosae, transudation of 
fluids and decreased mucociliary function. Microorganisms 
grow in this environment within the sinus, which increa-
ses inflammatory reactions.6,7 Anatomical variations of the 
nasal septum, middle turbinates and uncinate process are 
predisposing factors because they result in stenosis and 
may impede ventilation, which worsens the condition.1,7
Rhinosinusitis is usually time-defined according 
to frequency and duration of disease;1-4 it is commonly 
classified as four subtypes: acute (sudden onset, lasting 
up to four weeks), recurring (over four yearly episodes 
with full resolution between each), subacute (persisting 
after four weeks and remaining for over 12 weeks, but less 
intensely), and chronic (persisting for over 12 weeks).1,8 
Signs and symptoms are similar in any subtype; the clinical 
picture is what varies. There is rhinorrhea, significant nasal 
block, dry coughing that worsens at night, throat clearing, 
cacosmia, halitosis, hyposmia, and nasal bleeding in the 
chronic phase.1-8
Predisposing factors - such as duration and fre-
quency of crises - are relevant for defining appropriate 
therapy in chronic rhinosinusitis.1-8 Recent studies have 
recommended using systemic or topical drugs and adju-
vant therapy.1,3,8 Aspiration of nasal sinuses is indicated if 
hosts are immunocompromised, severely ill, or if antibiotic 
therapy is ineffective.8 Other studies have proposed using 
low intensity ultrasound therapy (LIUST) applied on the 
nose (maxillary and frontal sinuses).9-13
Ultrasound (1 to 3-MHz) is low power and low in-
tensity mechanical energy which is produced by passing 
a high frequency electrical current through a piezoelectric 
material.14-16 Sound waves propagate longitudinally in bio-
logical tissues; particles vibrate parallel to the direction of 
waves.15,16 The literature describes this continuous ultra-
sound wave as being able to increase the temperature of 
tissues - thereby causing thermal effects. Pulsed ultrasound 
waves act on a cell and/or molecular level by altering mem-
brane permeability, ionic concentration gradients and cell 
biochemical activity.14-17 More recently, ultrasound has been 
employed as adjuvant therapy in several conditions such 
as tissue repair,16 reduction of muscle and joint pain,17,18 
modulation of inflammation,19,20-22 and reduction of ten-
don adhesions.17-19 A few studies have demonstrated that 
LIUST-induced accelerated skin tissue repair results from 
local modulation of cell mediators/signalers such as nitric 
oxide, histamine and other cytokines that are involved in 
inflammation in healing; it also increases the number of 
fibroblasts and collagen synthesis.16-19 There are few pu-
blished clinical studies on LIUST as treatment or adjuvant 
therapy for chronic rhinosinusitis;9-12 it seems plausible 
that LIUST may reduce nasal block and congestion by its 
physical and chemical effects on tissues,13,21,22 reestablishing 
interstitial mucosal permeability, reducing the viscosity 
of paranasal sinus secretions and helping eliminate nasal 
discharges.13-15 Thus, the main purpose of this study was 
to evaluate the short-term effects of continuous 1 MHz 
LIUST on nasal block and the symptoms of subjects with 
chronic rhinosinusitis.
METHOD
An experimental study was carried out according 
to Brazilian and international standards for research in 
human beings (Regulation 196/96-CNS/OMS and others); 
the institutional review board approved this study (no. 
021/2007).
Study Design
A placebo-controlled experimental pre- and post-
test study was carried out to evaluate the short-term ef-
fects on nasal obstruction of continuous 1 MHz LIUST in 
subjects with chronic rhinosinusitis. The sample comprised 
26 patients with chronic rhinosinusitis that had undergone 
medical treatment for at least 12 weeks in an ENT outpa-
tient unit at our institution, and that were referred to the 




The inclusion criteria were as follows: patients of 
both sexes, aged from 18 to 60 years, diagnosed with rhi-
nosinusitis according to the Brazilian guidelines for this 
condition, treated medically for at least 12 weeks, currently 
not using systemic or topical (nasal) medication for at least 
one week, and upon signing a standard free informed 
consent form confirming their voluntary participation.
Exclusion criteria were: presence of chronic diseases 
(diabetes, arterial hypertension), smoking, fever, skin dis-
eases of the face (such as acne), nasal polyps, tumors or 
cysts (as verified with computed tomography), other facial 
skin lesions or allergies, and diseases that contraindicated 
LIUST or that might affect the final results. Participants 
were asked to maintain their usual diets, to refrain from 
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drinking caffeine-containing and alcoholic beverages, and 
to avoid taking systemic and/or topical nasal medication 
(especially sympathomimetic drugs) in the preceding 24 
hours before gathering data.
 
Groups and study protocol
After meeting enrolment criteria, 26 patients diag-
nosed with chronic rhinosinusitis (10 male and 16 female) 
were referred to the physical therapy unit and allocated 
sequentially to two groups by arrival order: odd numbered 
patients comprised the placebo-control group (CP group, 
n= 12) and even numbered patients comprised the treated 
group - 1-MHz ultrasound (US group, n= 14). All patients 
underwent the same procedures, done by the same re-
searcher; but the ultrasound probe was not connected to 
the ultrasound device (AVATAR IV® - KLD - Biosystems - 
São Paulo, Brazil) during the procedure. An evaluation by 
a physical therapist was carried out to investigate possible 
contraindications to LIUST on the face (maxillary sinuses 
and nasal septum).
In a ventilated room at 24oC during the afternoon, 
the participant’s vital signs and body weight and height 
(and body mass index) were measured. Subjects were 
asked to quantify their current main symptoms of chronic 
rhinitis (facial pain, nose block, rhinorrhea, throat clear-
ing, coughing and epistaxis) on a 0-10 visual analog scale.
The study protocol was started, consisting of placing 
subject in dorsal decubitus (head aligned longitudinally 
with the body) during 20 minutes for facial asepsis with 
topical antiseptics. Next, the total volume of secretions 
expelled (VSEx, mL) was measured; this was measured 
by instilling simultaneously 2.5 mL of saline (NaCl - 0.9%) 
in each nostril, collecting the expelled nasal lavage and 
storing for quantification. The degree of nasal obstruction 
and/or permeability was measured by the volume of air ex-
pelled (VAEx, cm2) as measured using a Glatzel mirror.23,24
After measuring the VSEx and VAEx, ultrasound gel 
(H
2
O) was placed over the maxillary sinuses and nasal sep-
tum, and low-intensity ultrasound was applied according 
to the following parameters: I
SATA
 (spatial average temporal 
average intensity) = 1-MHz, 1.0 W.cm-2, continuous mode, 
for 4 minutes. The 1-MHz ultrasound probe was system-
atically moved in circles over the maxillary sinuses and 
the nasal septum during 4 minutes.11,20 After 20 minutes 
of LIUST over the nose, the VSEx and VAEx were again 
measured, and the symptoms of chronic rhinosinusitis were 
quantified again on a visual analog scale in both groups. 
The 1-MHz ultrasound probe insonates over an effective 
area of 0.5 cm2; this was checked and calibrated before 
the study on precision scales at the Engineering Depart-
ment of the institution. The ultrasound insonation level 
(W.cm-2, 5%) in this study is the amount recommended for 
therapeutic ultrasound by the WFUMB (Word Federation 
Ultrasound Medicine and Biology) and the FDA (Food and 
Drug Administration).14
Data analysis
The sample size was calculated using the Statemat® 
2.0 software, which indicated an n = 24 subjects (patients 
with chronic rhinosinusitis) as an ideal sample for 90% 
test power and 0,05 alpha error. The variables were con-
sidered normal in the Shapiro-Wilk test, and values were 
expressed as means ± standard deviation (SD). The paired 
and non-pared Student’s t test was applied to check dif-
ferences among variables. Two-way analysis of variance 
(ANOVA) was applied to establish differences between the 
two groups, followed by the Tukey multiple comparison 
test (post hoc). The minimum significance level for the 
differences was p ≤ 0,05. The Prism 5.0® (GraphPad, San 
Diego, CA, USA) software was used for these analyses.
RESULTS
Table 1 shows the general features, body composi-
tion, and vital signs of subjects with chronic rhinosinus-
itis; there were no significant differences among these 
parameters in the CP and US groups (1-Mhz therapeutic 
ultrasound), characterizing the sample as homogeneous.
Table 2 shows the main symptoms in chronic 
rhinosinusitis subjects before and after applying 1-MHz 
nasal LIUST (US group) or placebo (CP group). Except for 
coughing and epistaxis, chronic rhinosinusitis symptoms 
regressed significantly in the US group compared with 
the CP group.
Figure 1A shows that VSEx values in the US group 
increased after LIUST (p ≤ 0,01), as opposed to these val-
ues in the CP group. Figure 1B shows a similar increase 
in VAEx values in the US group (p ≤ 0,01). This may be 
translated as a 64% decrease in nasal obstruction and 
Table 1. General features, body composition, and vital signs of sub-
jets with chronic rhinosinusitis
Variables CP (N= 12) US (N= 14) p-value
Male/Female 5 / 7 5 / 9 
Age (years) 26 ± 9 27 ± 13 0,212
Weight (Kg) 78 ± 2 72 ± 4 0,134
Body-mass index 
(Kg.cm-2)
30.3 ± 3 28.6 ± 4 0,097
Mean arterial blood 
pressure (mmHg)
102 ± 4 105 ± 1 0,163
Heart rate (bpm) 90 ± 3 92 ± 4 0,127
Respiratory rate 
(rpm)
18 ± 2 20 ± 3 0,118
Values are expressed as means ± standard deviation (SD). Student’s 
t test.
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congestion in chronic rhinosinusitis subjects treated with 
continuous 1-MHz LIUST, compared with subjects in the 
CP group. There were no significant pre- and post-test 
differences when applying LIUST with the probe switched 
off (placebo), as expected.
DISCUSSION
This study presents the short-term effects of nasal 
continuous mode 1 MHz LIUST on nasal block  and other 
symptoms of chronic rhinosinusitis. Our data showed that a 
single 4-minute application of 1 MHz LIUST at a 1.0 W.cm-2 
(SATA) dose on maxillary sinuses and the nasal septum 
yielded a significant increase in VSEx and VAEx values; it 
also resulted in a significant regression of other symptoms 
of chronic rhinosinusitis in the study group.
Our findings are similar to those of Naghdi et al.12 
and Ansari et al.9,10 who showed that the frequency of the 
main symptoms in chronic rhinosinusitis (facial pain, nasal 
congestion and nasal block, rhinorrhea, olfaction disorders, 
and coughing) decreased significantly following 1 and 
3 MHz LIUST. These studies showed that the thickness 
of the sinus mucosa decreased, the meatal ostia became 
more open, and paranasal sinus lesions regressed after the 
15th day of LIUST at 1.0 W.cm-2 (SATA) for 5 minutes over 
the maxillary and frontal sinuses.10,12 Studies by Barros et 
al.11 demonstrated that only two sessions of pulsed mode 
LIUST at 1.0 - 1.5 W.cm-2 for 3 minutes were not enough 
to decrease nasal block in 13 subjects with rhinosinusi-
tis - with or without antibiotics. However, this approach 
Table 2. Main symptoms of chronic rhinosinusitis before and after a 




CP (n = 12) US (n = 14)
Pre Post Pre Post
Facial pain 7,9 ± 0,2 7,3 ± 0,5 7,5 ± 0,5
2.1 ± 
0,2**++
Nose block 8,3 ± 0,2 8,0 ± 0,3 7,9 ± 0,4
3,0 ± 
0,5**++
Rhinorrhea 5,9 ± 0,3 6,3 ± 0,4 6,1 ± 0,3
2,0 ± 
0,2**++
Throat-clearing 5,0 ± 0,4 4,0 ± 0,5 4,9 ± 0,3
2,7 ± 
0,3*+ 
Coughing 1.8 ± 0,2 2,1 ± 0,3 1,9 ± 0,2 1,6 ± 0,4
Epistaxis 1,6 ± 0,1 1,8 ± 0,2 1,6 ± 0,2 1,4 ± 0,3
Values are expressed as means ± standard deviation. Visual analog 
scale or VAS (0-10). CP = placebo-control group, US = therapeutic 
ultrasound group, Student’s t test for paired samples, two-way analysis 
of variance (ANOVA) followed by the Tukey multiple comparison test 
(post hoc).
*p ≤ 0,05 e **p ≤ 0,01 for Pre- vs. Post-;
+p ≤ 0,05 + +p ≤ 0,01 for CP vs. US.
Figure 1. Effects of low-intensity ultrasound therapy (LIUST) on nasal 
block in subjects with chronic rhinosinusitis.  Panel (A), volume of nasal 
secretion expelled (VSEx, mL). Panel (B), volume of air expelled (VAEx, 
cm2) in the placebo-control (CP) group, and 1-MHz LIUST (1W.cm-2) 
insonated (US) groups - 1-MHz LIUST (1W.cm-2). Values are presented 
as means ± standard deviation. Student’s t test for paired samples, 
two-way analysis of variance (ANOVA), followed by the Tukey multiple 
comparison test (post hoc). *p ≤ 0.05 and **p ≤ 0.01 for Pre- vs. Post-; 
+p ≤ 0.05 + +p ≤ 0.01 for CP vs. US.
significantly reduced other symptoms such as headaches 
and facial pain in these subjects.
We found that continuous mode 1 MHz LIUST at 1.0 
W.cm-2 for 4 minutes over the maxillary sinuses and nasal 
septum not only reduced nasal block and congestion by 
64%, but also resulted in regression of the main symptoms 
of chronic rhinosinusitis (Table 1). It is worth pointing out 
that the short-term effects of nasal decongestion and relief 
of other symptoms in 90% of patients undergoing LIUST 
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lasted during the ensuing two hours, which confirms the 
therapeutic potential of LIUST in chronic rhinosinusitis.
Improvements in VSEx and VAEx levels - regression 
in nasal block and congestion and other symptoms such 
as facial pain, rhinorrhea and throat-clearing - in patients 
with chronic rhinosinusitis following a single application of 
LIUST was probably due to the mechanical effects (vibra-
tion)14-16 of ultrasound on the nasal mucosa and discharge. 
Studies have shown that therapeutic ultrasound changes 
the thixotropy in the nasosinusal mucosa, which is the 
ability of a semisolid material (mucus) to progressively 
become fluid because of mechanical agitation and to return 
to its original state after a period of rest.14-16,25 Studies have 
shown that the nasosinusal mucus is partially thixotropic; it 
does not return to its original rheologic state after mixing 
has ceased.25 This correlates with our findings, as VSEx 
values increased significantly, which suggests that there 
was a mucolytic effect that resulted in elimination of nasal 
secretions by lavage, as observed in patients with chronic 
rhinosinusitis.25-28
Similarly, the observed effects on VSEx and VAEx 
and on other symptoms of chronic rhinosinusitis may have 
taken place because of an increased local temperature - the 
known thermal effects of continuous LIUST. These effects 
also change the viscoelastic (rheologic) properties of the 
nasosinusal mucus by breaking the disulphide bonds of 
mucoproteins26-28 thereby changing the fluidity of nasal 
secretions, which therefore drain more easily after nasal 
lavage in the LIUST-treated group.13-15,25-28 Nasal lavage 
with saline solution only - without LIUST - did not have 
the same effect on VSEx, VAEx, and on other symptoms 
of chronic rhinosinusitis in the placebo-control.
The direct effects of low-intensity ultrasound on 
biological tissues cannot be discarded;14,16 these effects 
may affect cell membrane permeability,15-17,20,21 enzyme 
activity and inflammation,19,21,29 and may facilitate local 
fibrinolysis.17-22 LIUST has been shown to modify cellular 
and humoral signaling factors, especially the bioavailability 
of nitrous oxide, thereby regulating interstitial permeabi-
lity and tissue fluid balance;9,12,13,29 this in turn results in 
decongestion of the nasopharyngeal mucosa, regression 
of interstitial edema and of nasal obstruction/congestion 
in patients with chronic rhinosinusitis. Supporting this 
assumption, recent reports in the literature have shown 
strong correlations among nasal mucosa congestion rates, 
fibrosis, and vascular density in patients with chronic rhi-
nosinusitis.30 Thus, fibrosis and vascular density are directly 
associated with the level of congestion of the nasal mucosa.
CONCLUSION
Based on our results and the literature, we conclude 
that applying continuous 1-MHz LIUST at 1 W/cm2 during 
4 minutes over the maxillary sinuses and nasal septum 
results in decreased nasal obstruction and improved na-
sal airflow. The clinical outcome in patients with chronic 
rhinosinusitis is improved and new possibilities open up 
for LIUST in respiratory physical therapy. Notwithstanding 
these clinical benefits, we underline the need for addi-
tional studies using different parameters to characterize 
these therapeutic mechanisms in more detail, and to find 
possible adverse effects of therapeutic LIUST in chronic 
rhinosinusitis. Furthermore, patients should be carefully 
assessed to avoid wrong diagnoses and delayed treatment, 
thereby avoiding complications of the disease.
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